CompletedNCT02185131
Mirtazapine Compared With Placebo for Depression and Alcohol Use
About this title
Read the official source — NCT02185131Medication studyAges 18–55United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02185131
- Official title
Show the full official title
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Did this study involve medication?
Yes. The study involved medication, including Mirtazapine and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
